VF
AVEO

Virtu Financial’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Virtu Financial’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10,342
Closed -$64K – 2471
2021
Q3 		$64K Buy
+10,342
New +$61.9K 0.01% 1236
2021
Q2 		– Sell
-33,081
Closed -$242K – 2420
2021
Q1 		$242K Buy
+33,081
New +$285K 0.02% 952
2020
Q4 		– Sell
-24,577
Closed -$146K – 1995
2020
Q3 		$146K Buy
+24,577
New +$122K 0.03% 655
2019
Q4 		$145K Buy
23,256
+6,789
+41% +$50K 0.01% 1014
2019
Q3 		$139K Buy
16,467
+13,840
+527% +$103K 0.01% 1033
2019
Q2 		$18K Sell
2,627
-11,332
-81% -$97.1K ﹤0.01% 1358
2019
Q1 		$114K Buy
13,959
+7,167
+106% +$74K 0.01% 1114
2018
Q4 		$109K Buy
+6,792
New +$149K 0.01% 1111
2018
Q1 		– Sell
-3,859
Closed -$108K – 2932
2017
Q4 		$108K Buy
+3,859
New +$120K 0.01% 1895

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Virtu Financial's AVEO Position: Q4 2021 in Review

Virtu Financial sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q4 2021, closing a stake of 10,342 shares — an estimated $64K sold.

Virtu Financial first reported a position in AVEO in Q4 2017 and held it in 9 quarters. The position peaked at $242K in Q1 2021. 58 funds tracked by Wall St. Rank hold AVEO as of Q4 2021.

  • Virtu Financial reported no remaining AVEO Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
  • Virtu Financial sold 10,342 AVEO Pharmaceuticals, Inc. shares in Q4 2021, an estimated $64K.
  • Virtu Financial first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2017 and held it in 9 quarters.
  • Virtu Financial's AVEO Pharmaceuticals, Inc. position peaked at $242K in Q1 2021.
  • 58 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q4 2021.

Based on Virtu Financial's 13F filing for Q4 2021, filed 17 Feb 2022.